A single laboratory-based HIV viral load test used by U.S. clinicians who provide people with long-acting, injectable cabotegravir (CAB-LA) HIV pre-exposure prophylaxis (PrEP) did not reliably detect ...

HIV-1 viral load monitoring is central to the effective management and treatment of HIV infection. Accurate quantification of viral RNA in plasma not only guides antiretroviral therapy but also offers ...

According to the U.S. Centers for Disease Control and Prevention (CDC) and other sources, there are approximately 1.2 million people living with HIV in the United States, and another 1.2 to 2.2 ...

Low HIV viral load appears to raise the risk for new cardiovascular events in people with HIV, indicating the need for tailored prevention and testing of novel interventions.

Most women living with HIV achieved an immunologic response after 2 years of initiating antiretroviral therapy. A higher baseline HIV viral load increased the odds of an immunologic response in women ...

Women with HIV in British Columbia accurately self-reported viral load, unaffected by sociodemographic factors, with 91% accuracy. High concordance (91%) was found between self-reported and clinical ...